Sio Gene Therapies Inc

NASDAQ:SIOX  
1.39
-0.10 (-6.71%)
Earnings Announcements

Sio Gene Therapies Reports Q2 Loss Per Share Of $0.29

Published: 11/12/2021 12:58 GMT
Sio Gene Therapies Inc (SIOX) - Q2 Loss per Share $0.29.
Estimate That Current Cash and Cash Equivalents Will Sustain Operations Into Calendar Q4 2022.
Q2 Earnings per Share View $-0.17 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.